Resultados de búsqueda - Ang, Agnes
- Mostrando 1 - 10 Resultados de 10
-
1
Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study por Lumbantoruan, Christina, Kermode, Michelle, Giyai, Aloisius, Ang, Agnes, Kelaher, Margaret
Publicado 2018Texto -
2
-
3
Recycling endosomes can serve as intermediates during transport from the Golgi to the plasma membrane of MDCK cells por Ang, Agnes Lee, Taguchi, Tomohiko, Francis, Stephen, Fölsch, Heike, Murrells, Lindsay J., Pypaert, Marc, Warren, Graham, Mellman, Ira
Publicado 2004Texto -
4
MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma por Catenacci, Daniel V. T., Ang, Agnes, Liao, Wei‐Li, Shen, Jing, O'Day, Emily, Loberg, Robert D., Cecchi, Fabiola, Hembrough, Todd, Ruzzo, Annamaria, Graziano, Francesco
Publicado 2016Texto -
5
Frequency of S492R mutations in the epidermal growth factor receptor: analysis of plasma DNA from patients with metastatic colorectal cancer treated with panitumumab or cetuximab m... por Price, Timothy, Ang, Agnes, Boedigheimer, Michael, Kim, Tae Won, Li, Jin, Cascinu, Stefano, Ruff, Paul, Satya Suresh, Attili, Thomas, Anne, Tjulandin, Sergei, Peeters, Marc
Publicado 2020Texto -
6
Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network por Yeaman, Charles, Ayala, M. Inmaculada, Wright, Jessica R., Bard, Frederic, Bossard, Carine, Ang, Agnes, Maeda, Yusuke, Seufferlein, Thomas, Mellman, Ira, Nelson, W. James, Malhotra, Vivek
Publicado 2004Texto -
7
ATIM-49 (LTBK-01). AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE(®)) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (R... por Rosenthal, Mark A, Balana, Carmen, van Linde, Myra E, Sayehli, Cyrus, Fiedler, Walter M, Wermke, Martin, Massard, Christophe, Mellinghoff, Ingo K, Khasraw, Mustafa, Ang, Agnes, Rasmussen, Erik, Kast, Johannes, Stienen, Sabine, Cloughesy, Timothy F
Publicado 2019Texto -
8
Molecular Analysis of Non-Small Cell Lung Cancer (NSCLC) Identifies Subsets with Different Sensitivity to Insulin like Growth Factor I Receptor (IGF-IR) Inhibition por Gualberto, Antonio, Dolled-Filhart, Marisa, Gustavson, Mark, Christiansen, Jason, Wang, Yu-Fen, Hixon, Mary L., Reynolds, Jennifer, McDonald, Sandra, Ang, Agnes, Rimm, David L., Langer, Corey J., Blakely, Johnetta, Garland, Linda, Paz-Ares, Luis G., Karp, Daniel D., Lee, Adrian V.
Publicado 2010Texto -
9
Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, dou... por Catenacci, Daniel V T, Tebbutt, Niall C, Davidenko, Irina, Murad, André M, Al-Batran, Salah-Eddin, Ilson, David H, Tjulandin, Sergei, Gotovkin, Evengy, Karaszewska, Boguslawa, Bondarenko, Igor, Tejani, Mohamedtaki A, Udrea, Anghel A, Tehfe, Mustapha, De Vita, Ferdinando, Turkington, Cheryl, Tang, Rui, Ang, Agnes, Zhang, Yilong, Hoang, Tien, Sidhu, Roger, Cunningham, David
Publicado 2017Texto -
10
Diverse alterations associated with resistance to KRAS(G12C) inhibition por Zhao, Yulei, Murciano-Goroff, Yonina R., Xue, Jenny Y., Ang, Agnes, Lucas, Jessica, Mai, Trang T., Da Cruz Paula, Arnaud F., Saiki, Anne, Mohn, Deanna, Achanta, Pragathi, Sisk, Ann-Elizabeth, Arora, Kanika S., Roy, Rohan S., Kim, Dongsung, Li, Chuanchuan, Lim, Lee P., Li, Mark, Bahr, Amber, Loomis, Brian R., de Stanchina, Elisa, Reis-Filho, Jorge, Weigelt, Britta, Berger, Michael, Riely, Gregory, Arbour, Kathryn C., Russell Lipford, J., Li, Bob T., Lito, Piro
Publicado 2021Texto